This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Nov;11(11):621.

doi: 10.1038/nrcardio.2014.148. Epub 2014 Sep 16.

Acute coronary syndromes: Risk of major coronary events not reduced by darapladib therapy

PMID: 25223450
DOI: 10.1038/nrcardio.2014.148

Comment

Acute coronary syndromes: Risk of major coronary events not reduced by darapladib therapy

João H Duarte. Nat Rev Cardiol. 2014 Nov.

. 2014 Nov;11(11):621.

doi: 10.1038/nrcardio.2014.148. Epub 2014 Sep 16.

Author

PMID: 25223450
DOI: 10.1038/nrcardio.2014.148

No abstract available

PubMed Disclaimer

Comment on

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators; Steen DL. O'Donoghue ML, et al. JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. JAMA. 2014. PMID: 25173516 Clinical Trial.

References

1. JAMA. 2014 Sep 10;312(10):1006-15 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.